Li CX, He Q, Wang ZY, Fang C, Gong ZC, Zhao HR, Ling B (2023) Risk assessment of venous thromboembolism in head and neck cancer patients and its establishment of a prediction model. Head Neck 45(10):2515–2524
Li CX, Sun JL, Gong ZC, Liu H, Ding MC, Zhao HR (2023) An umbrella review exploring the effect of radiotherapy for head and neck cancer patients on the frequency of jaws osteoradionecrosis. Cancer Radiother 27(5):434–446
Article CAS PubMed Google Scholar
Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics. CA Cancer J Clin 72(1):7–33
Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495(7441):384–388
Article CAS PubMed Google Scholar
Jimenez L, Jayakar SK, Ow TJ, Segall JE (2015) Mechanisms of invasion in head and neck cancer. Arch Pathol Lab Med 139(11):1334–1348
Article CAS PubMed PubMed Central Google Scholar
Manasa VG, Kannan S (2017) Impact of microRNA dynamics on cancer hallmarks: an oral cancer scenario. Tumour Biol 39(3):1010428317695920
Article CAS PubMed Google Scholar
Karatas OF, Oner M, Abay A, Diyapoglu A (2017) MicroRNAs in human tongue squamous cell carcinoma: from pathogenesis to therapeutic implications. Oral Oncol 67:124–130
Article CAS PubMed Google Scholar
Liu T, Chen G, Sun D, Lei M, Li Y, Zhou C, Li X, Xue W, Wang H, Liu C, Xu J (2017) Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma. Acta Biochim Biophys Sin 49(9):808–816 (Shanghai)
Article CAS PubMed Google Scholar
Sun SS, Zhou X, Huang YY, Kong LP, Mei M, Guo WY, Zhao MH, Ren Y, Shen Q, Zhang L (2015) Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma. Mol Cancer 14:213
Article PubMed PubMed Central Google Scholar
Li J, Huang H, Sun L, Yang M, Pan C, Chen W, Wu D, Lin Z, Zeng C, Yao Y, Zhang P, Song E (2009) MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15(12):3998–4008
Article CAS PubMed Google Scholar
He Q, Chen Z, Cabay RJ, Zhang L, Luan X, Chen D, Yu T, Wang A, Zhou X (2016) microRNA-21 and microRNA-375 from oral cytology as biomarkers for oral tongue cancer detection. Oral Oncol 57:15–20
Article CAS PubMed PubMed Central Google Scholar
Supic G, Zeljic K, Rankov AD, Kozomara R, Nikolic A, Radojkovic D, Magic Z (2018) miR-183 and miR-21 expression as biomarkers of progression and survival in tongue carcinoma patients. Clin Oral Investig 22(1):401–409
Arantes LM, Laus AC, Melendez ME, de Carvalho AC, Sorroche BP, De Marchi PR, Evangelista AF, Scapulatempo-Neto C, de Souza VL, Carvalho AL (2017) MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol. Oncotarget 8(6):9911–9921
Karimi A, Bahrami N, Sayedyahossein A, Derakhshan S (2020) Evaluation of circulating serum 3 types of microRNA as biomarkers of oral squamous cell carcinoma; a pilot study. J Oral Pathol Med 49(1):43–48
Article CAS PubMed Google Scholar
Arya S, Kaji AH, Boermeester MA (2021) PRISMA reporting guidelines for meta-analyses and systematic reviews. JAMA Surg 156(8):789–790
Qu YJ, Yang ZR, Sun F, Zhan SY (2018) Risk on bias assessment: (6) a revised tool for the Quality Assessment on Diagnostic Accuracy Studies (QUADAS-2). Zhonghua Liu Xing Bing Xue Za Zhi 39(4):524–531
Li C, Matthies L, Hou X, Knipfer C, Gosau M, Friedrich RE (2020) A meta-analysis of the pros and cons of partial superficial parotidectomy versus superficial parotidectomy for the treatment of benign parotid neoplasms. J Craniomaxillofac Surg 48(6):590–598
Melsen WG, Bootsma MC, Rovers MM, Bonten MJ (2014) The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect 20(2):123–129
Article CAS PubMed Google Scholar
Hsu CM, Lin PM, Wang YM et al (2012) Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumour Biol 33(6):1933–1942
Article CAS PubMed Google Scholar
Erkul E, Yilmaz I, Gungor A, Kurt O, Babayigit MA (2017) MicroRNA-21 in laryngeal squamous cell carcinoma: diagnostic and prognostic features. Laryngoscope 127(2):E62–E66
Article CAS PubMed Google Scholar
Hu A, Huang JJ, Xu WH, Jin XJ, Li JP, Tang YJ, Huang XF, Cui HJ, Sun GB (2014) miR-21 and miR-375 microRNAs as candidate diagnostic biomarkers in squamous cell carcinoma of the larynx: association with patient survival. Am J Transl Res 6(5):604–613
Ren W, Qiang C, Gao L, Li SM, Zhang LM, Wang XL, Dong JW, Chen C, Liu CY, Zhi KQ (2014) Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma. Biomarkers 19(7):590–596
Article CAS PubMed Google Scholar
Gu XJ, Wang TY, Liu XQ, Xu S, Zhang GX (2016) Clinical significance and immunohistochemical expression of miRNA-21 in whole saliva of OSCC patients. J Oral Maxil Surg 26(5):323–327
Ishinaga H, He F, Hou B, Shah S, Murata M, Takeuchi K (2019) A longitudinal study on circulating miR-21 as a therapeutic effect marker in head and neck squamous cell carcinoma. Carcinogenesis 11:bgz075
Lu Z, He Q, Liang J, Li W, Su Q, Chen Z, Wan Q, Zhou X, Cao L, Sun J, Wu Y, Liu L, Wu X, Hou J, Lian K, Wang A (2019) miR-31-5p is a potential circulating biomarker and therapeutic target for oral cancer. Mol Ther Nucleic Acids 16:471–480
Article CAS PubMed PubMed Central Google Scholar
Mahmood N, Hanif M, Ahmed A, Jamal Q, Mushtaq S, Khan A, Saqib M (2019) Circulating miR-21 as a prognostic and predictive biomarker in oral squamous cell carcinoma. Pak J Med Sci 35(5):1408–1412
Article PubMed PubMed Central Google Scholar
Brito JA, Gomes CC, Guimarães AL, Campos K, Gomez RS (2014) Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia. J Oral Pathol Med 43(3):211–216
Article CAS PubMed Google Scholar
Yap T, Koo K, Cheng L, Vella LJ, Hill AF, Reynolds E, Nastri A, Cirillo N, Seers C, McCullough M (2018) Predicting the presence of oral squamous cell carcinoma using commonly dysregulated microRNA in oral swirls. Cancer Prev Res 11(8):491–502 (Phila)
Li CX, Sun JL, Gong ZC, Lin ZQ, Liu H (2017) Prognostic value of GLUT-1 expression in oral squamous cell carcinoma: a PRISMA-compliant meta-analysis. Medicine 95(45):e5324 (Baltimore)
Peltanova B, Raudenska M, Masarik M (2019) Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Mol Cancer 18(1):63
Article PubMed PubMed Central Google Scholar
Kim T, Croce CM (2023) MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies. Exp Mol Med 55(7):1314–1321
Article CAS PubMed PubMed Central Google Scholar
Kabzinski J, Kucharska-Lusina A, Majsterek I (2023) RNA-based liquid biopsy in head and neck cancer. Cells 12(14):1916
Article CAS PubMed PubMed Central Google Scholar
Jamali Z, AslAminabadi N, Attaran R, Pournagiazar F, GhertasiOskouei S, Ahmadpour F (2015) MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol 51(4):321–331. https://doi.org/10.1016/j.oraloncology.2015.01.008
Article CAS PubMed Google Scholar
Wang P, Xu L, Li L, Ren S, Tang J, Zhang M, Xu M (2019) The microRNA-375 as a potentially promising biomarker to predict the prognosis of patients with head and neck or esophageal squamous cell carcinoma: a meta-analysis. Eur Arch Otorhinolaryngol 276(4):957–968. https://doi.org/10.1007/s00405-019-05325-8
Troiano G, Mastrangelo F, Caponio VCA, Laino L, Cirillo N, Lo ML (2018) Predictive prognostic value of tissue-based microRNA expression in oral squamous cell carcinoma: a systematic review and meta-analysis. J Dent Res 97(7):759–766. https://doi.org/10.1177/0022034518762090
Irimie-Aghiorghiesei AI, Pop-Bica C, Pintea S, Braicu C, Cojocneanu R, Zimța AA, Gulei D, Slabý O, Berindan-Neagoe I (2019) Prognostic value of miR-21: an updated meta-analysis in head and neck squamous cell carcinoma (HNSCC). J Clin Med 8(12):2041
Comments (0)